Keith Kerr

Medicine & Life Sciences

1. Non-Small Cell Lung Carcinoma 100%
2. Lung Neoplasms 62%
3. Neoplasms 39%
4. Adenocarcinoma of Lung 37%
5. Biomarkers 37%
6. Lung 24%
7. Hypoxia 23%
8. Survival 21%
9. Serpins 21%
10. Tertiary Lymphoid Structures 21%
11. Takotsubo Cardiomyopathy 20%
12. Endogenous Retroviruses 20%
13. Angiogenesis Inhibitors 20%
14. Drug Therapy 20%
15. Air Pollutants 19%
16. Squamous Cell Neoplasms 18%
17. Congresses 18%
18. Immunotherapy 18%
19. Mutation 18%
20. Platinum 18%
21. Aortic Valve Stenosis 16%
22. Therapeutics 16%
23. Positron Emission Tomography Computed Tomography 16%
24. Precision Medicine 16%
25. Protease Inhibitors 15%
26. Cell Biology 15%
27. Aortic Valve 15%
28. Crohn Disease 14%
29. ErbB Receptors 14%
30. Transcriptome 13%
31. Theoretical Models 12%
32. Colorectal Neoplasms 12%
33. Clobetasol 11%
34. Systematic Reviews 11%
35. Monoclonal Antibodies 11%
36. Ligands 10%
37. Down-Regulation 10%
38. Immunohistochemistry 10%
39. Vascular Endothelial Growth Factor Receptor-1 10%
40. Minocycline 9%
41. Thalidomide 9%
42. Skin Transplantation 9%
43. T-Lymphocytes 9%
44. Apoptosis 9%
45. Molecular Pathology 8%
46. Penis 8%
47. Antibodies 8%
48. fluoroazomycin arabinoside 8%
49. Skin 8%
50. Prednisolone 7%